Abstract
Breast cancer, like several other solid tumors, has the capacity to metastasize to the liver, with a dismal prognosis.
Keywords
- Breast Cancer
- Liver Metastasis
- Hepatic Metastasis
- Hepatic Arterial Infusion
- Hepatic Arterial Infusion Chemotherapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jaffe BM, Donegan WL. Factors influencing survival in patients with untreated hepatic metastasis. Surg Gynecol Obstet 1968; 127: 1–11.
Hoe AL, Royle GT, Taylor I. Breast liver metastases — incidence, diagnosis and outcome. J R Soc Med 1991; 84 (12): 714–716.
Santoro E, Vitucci C, Carlini M, et al. Liver metastasis of breast carcinoma. Chir Ital 2000; 52 (2): 131–137.
Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59 (2): 177–1.
Selzner M, Morse MA, Vderenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127 (4): 383–389.
Joensuu H, Holli K, Heikkinen E et al. Combination chemotherapy versus single-agent therapy as first and second line treatment in metastatic breast cancer: a prospective randomized trial. J Clin Oncol 1998; 16 (12): 3720–3730.
Barone RM, Bayfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S. Inta-arterial chemo- therapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 1982; 50: 850–862.
Sullivan R. Systemic and arterial infusion chemotherapy for metastatic liver cancer. Int J Radiat Oncol Biol Phys 1976; 1: 973–976.
Trudeau ME. Phase I-II studies oh docetaxel as single agent in the treatment of metastatic breast cancer. Semin Oncol 1999; 28 (Supp18): 21–26.
Sparano J. Novel combination chemotherapy regimens for metastatic breast cancer. The 21st San Antonio Breast cancer Simposium. December 12–15, 1998.
Cocconi G, De Lisi V, Boni C, et al. Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer. Cancer 1983; 51: 581–588.
Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol 1965; 93: 200–208.
Phillips R. Roentgentherapy of hepatic metastases. Am JRoentg Ther Nucl Med 1954; 71: 826–834.
Borgelt BB, Gelber R, Brady LW, Griffin T, Hendricksson FR. The palliation of hepatic metastases: Results of the Radiation Therapy Oncology Group pilot Study. Int J Radiat Oncol Biol Phys 1981; 7: 587–591.
Heimdal K, Hannisdal E, Fossa SD. Survival after palliative radiotherapy of liver metastases. Acta Oncol 1988; 27: 63.
Kagan AR. Dose-time relationships in the palliation of metastases to liver, lung, brain and bone metastases. Front Radiat Ther Oncol 1988; 22: 165-
Thames HD, Peters LJ, Withers RH, Fletcher GH. Accelerated fractionation vs hyper fractionation. Rationale for several treatments per day. Int J Radiat Oncol Biol Phys 1983; 9: 127–138.
Thames HD, Withers RH, Peters LJ, Fletcher GH. Changes in early and late radiation response with alterated dose fractionation. Implication for dose-survival relationships. Int JRadiat Oncol Biol Phys 1982; 8: 219–226.
Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose esclating protocol. Int JRadiat Oncol Biol Phys 1993; 27: 117–123.
Lokich J, Kinsella T, Perri J Malcom A, Clouse M. Concomitant hepatic radiation and intraarterial pyrimidine therapy: correlation of liver scan, liver function test and plasma CEA with tumor response. Cancer 1981; 48: 2569–2574.
Kinsella T.I. The role of radiation therapy alone and combined with infusion of chemotherapy for treating liver metastaes. Sem Oncol 1983; 10: 215–22.
Rotman M, Kuruvilla AM, Choi K, Bhutiani I, Aziz H, Rosentha J, Braverman A et al. Response of colo-rectal Hepatic metastases to concomitant radiotherapy and intravenous infusion 5-fluorouracil. Int J Radiat Oncol Biol Phys 1986; 12: 2179–2187.
Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacological requirements for obtaining sensistization of human tumor cells in vitro to combined 5-fluorouracil or ftorafu and x-rays. IntJRadiat Oncol Biol Phys 1982; 8: 1923–1933.
Fu K, Rayner BS, Lam K. Modification of effects of continuous low dose irradiation by concurrent chemotherapy infusion. Int J Radial Oncol Biol Phys 1984; 10: 1473–1478.
Nakajima V, Miyamoto N, Tanabe M, Watanabe I, Terasima T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res 1979; 39: 3763–3767.
Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17: 354–357.
Dobrowsky W, Dobrowsky E, Strassl H, Braun O, Scheibers V. response to peoperative radio-chemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer. EurJ Cancer Clin Oncol 1989; 25: 845–849.
Steel GG, Peckham MJ. Expoitable mechanism in combined radiotherapy-chemotherapy: the concept of additivity. Int JRadiat Oncol Biol Phys 1979; 5: 85–91.
Kennedy KA, Rockwell S, Sartorelli AC. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 1980; 40: 2356–2360.
Seifert P, Baker LH, Reed ML, Vaitkevicius VK. Comparison of continuously infused 5-Fluorouracil with bolus injection in treatment of patients with colorectal cancer. Cancer 1975; 36: 123–128.
Peretz T, Freund HR, Isacson R et al. Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump. Isr J Med Sci 1988; 24: 562–567.
Mohiuddin M, Chen E, Ahmad N. combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996; 14: 722–728.
Aray Y, Sone Y, Inaba Y, Ariyoshi Y, Kido C. Hepatic arterial infusion chemotherapy for liver metastases from breast cancer. Cancer Chemother Pharmacol 1994; 33S: 141–144.
Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver metastases from breast cancer. JSurg Oncol 1994; 55 (1): 26–31.
Ausili Cefaro G, Smaniotto D, De Renzis C. Radiotherapy of hepatic metastases. Acta Med Rom 1986; 24: 143–148.
Nardone L, Salvi G, Brizi MG, Caspiani O, Abu Rumeileh I. Trattamento integrato radiochemioterapico concomitante per le metastasi epatiche da carcinoma mammario. In: Squillaci S: “Neoplasie epatiche e pancreatiche” — Monduzzi Editore, 1993, 253–257.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ausili, C.G., Nardone, L., Marmiroli, G., Manfrida, S., Salvi, G. (2002). Radiochemotherapy of Liver Metastases from Breast Cancer: Review of Literature and Personal Experience. In: Farinon, A.M. (eds) Advances in Abdominal Surgery 2002. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0637-7_9
Download citation
DOI: https://doi.org/10.1007/978-94-017-0637-7_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6135-5
Online ISBN: 978-94-017-0637-7
eBook Packages: Springer Book Archive